Investor


Information for Investors

We are continuously working to expand our business and are open to the possibilities of joining hands with fellows in pharmaceutical industries in order to ensure our quality products are available to our customers.

Disclosure of information

  • Sort by : Newest
  • BOD Resignation, 20 October 2022, 20 October 2022

    Keterbukaan Informasi PT Taisho Pharmaceutical Indonesia Tbk (“Perseroan”) Dalam rangka memenuhi ketentuan Pasal 9 Peraturan Otoritas Jasa Keuangan Nomor 33/POJK.04/2014 tentang Direksi dan Dewan Komisaris Emiten atau Perusahaan Publik (“POJK 33/2014”), dengan ini kami mengumumkan bahwa pada... more..

  • BOD Resignation September 2022, 29 September 2022

    Keterbukaan Informasi PT Taisho Pharmaceutical Indonesia Tbk (“Perseroan”) Dalam rangka memenuhi ketentuan Pasal 9 Peraturan Otoritas Jasa Keuangan Nomor 33/POJK.04/2014 tentang Direksi dan Dewan Komisaris Emiten atau Perusahaan Publik (“POJK 33/2014”), dengan ini kami mengumumkan bahwa pada... more..

  • BOD Resignation May 2020, 15 May 2020

    Disclosure of Information PT Taisho Pharmaceutical Indonesia Tbk (the “Company”) For the purpose of compliance with the provision of Article 9 of the Regulation of Financial Services Authority Number 33/POJK.04/2014 regaring the Board of Directors and Board of Commissioners of Issuers or Public ... more..

  • BOD Resignation 2020, 04 March 2020

    Disclosure of Information PT Taisho Pharmaceutical Indonesia Tbk (the “Company”) For the purpose of compliance with the provision of Article 9 of the Regulation of Financial Services Authority Number 33/POJK.04/2014 regaring the Board of Directors and Board of Commissioners of Issuers or Public ... more..

  • Delisting Information, 23 March 2018

    DISCLOSURE OF INFORMATION PT. Taisho Pharmaceutical Indonesia Tbk(the “Company”) Line of Business:Pharmaceutial Industry, Phone:+62 21 520 6720, Faks:+62 21 520 6735 For the purpose of compliance with the Financial Services Authority Regulation Number 31/POJK.04/2015 on Disclosure of Material I... more..

  • Shares Purchase Offering, 25 December 2017

    ANNOUNCEMENT Share Purchase Period 18 – 22 December 2017 Payment Date 3 January 2018 SHARES PURCHASE OFFERING PT. Taisho Pharmaceutical Indonesia Tbk (the “Company”) Domiciled in South Jakarta Line of Business: Pharmaceutical Industry Head Office: Wisma Tamara Lt. 10, Jl.Jend. Sudirman Kav.... more..

  • BOD Resignation, 02 November 2016

    DISCLOSURE OF INFORMATION PT. TAISHO PHARMACEUTICAL INDONESIA TBK -It is hereby announced than on 31 October 2016 the Board of Directors of PT. Taisho Pharmaceutical Indonesia Tbk, domiciled in South Jakarta and having its address at Tamara Center Building, 10th Floor, Jl. Jenderal Sudirman Kav. ... more..